Molecular Genetic Pathology Fellowship
The Molecular Genetic Pathology Fellowship is a 1-year ACGME-accredited program sponsored by the Department of Pathology. Fellows rotate through the Molecular Diagnostics labs at UT Southwestern's BioCenter and Children’s Health℠, while Clinical Genetics rotations are at Children’s Health, Harold C. Simmons Comprehensive Cancer Center, and Parkland Hospital. Rotations in Anatomic Pathology, when needed, are done at William P. Clements Jr. University Hospital. The Fellowship qualifies the trainee to sit for the ABP-ABMG Molecular Genetic Pathology certification examination.
The Fellowship Program will educate fellows in molecular and clinical genetics through assay development, troubleshooting, specimen sign-out, lab management, clinician consultation, and hands-on patient evaluation. Attendance is mandatory at a laboratory/clinical lecture series given throughout the year. Fellows will participate in journal clubs, molecular and clinical conferences, and can attend research and clinical seminars to fit their interests. Fellows will also have the opportunity to teach pathology residents and interact with fellows in other disciplines. Participation in a translational or clinical research project is strongly encouraged.
The laboratories receive solid and hematopoietic tumor, infectious disease, HLA, and clinical genetics cases for testing by real-time PCR, fragment analysis, Sanger sequencing, next generation sequencing, primer extension (Sequenom mass spec), DNA arrays, FISH, and traditional PCR.
Fellowship Application Requirements
Candidates should be board-eligible or certified in AP, CP, or Medical Genetics.
Commensurate with the applicant's level of training.
Applications for the single position should be received no later than November 1 of the year prior to start of the Molecular Genetic Pathology Fellowship, but a candidate may be accepted before this date so earlier applications are encouraged. In addition to the application form, three letters of reference are required. One should be from the applicant’s Residency Program Director and the other two from faculty most familiar with the applicant’s demonstrated interests and work in molecular pathology or clinical genetics.